NCT06796803
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
- Zhongshan Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Potentially Resectable Hepatocellular Carcinoma
Explore clinical trials studying Potentially Resectable Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Potentially Resectable Hepatocellular Carcinoma trial results
Not Yet Recruiting
Study on the Combined Treatment of Hepatocellular Carcinoma With Envafolimab, Suvemcitug and HAIC Conversion
NCT07738055
- Conditions
- Potentially Resectable Hepatocellular Carcinoma
- Locations
-
Not specified
Not Yet Recruiting
A Study of HAIC Combined With Lenvatinib and Envolizumab in Potentially Resectable Hepatocellular Carcinoma
NCT06143579
- Conditions
- Potentially Resectable Hepatocellular Carcinoma
- Locations
-
Not specified